| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269523 | HPB | 2011 | 9 Pages |
Abstract
RFA allows patients to be maintained longer on the waiting list without negative consequences on drop-off or survival compared with no treatment. Post-transplant outcomes are affected more by tumour characteristics than RFA or wait time.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Derek A. DuBay, Charbel Sandroussi, John R. Kachura, Chia Sing Ho, J. Robert Beecroft, Charles M. Vollmer, Anand Ghanekar, Markus Guba, Mark S. Cattral, Ian D. McGilvray, David R. Grant, Paul D. Greig,